Nervgen remyelination drug phase 1
Re: Nervgen remyelination drug phase 1
https://finance.yahoo.com/news/nervgen- ... 01%20Trial
"...Phase 1 program supports plan to start clinical trials in H2 2022 for NervGen's NVG-291 in spinal cord injury, multiple sclerosis and Alzheimer's disease indications
Screening of healthy volunteers has already started for the trial's multiple ascending dose (MAD) portion
In preclinical studies, NVG-291 has been shown to promote repair of nervous system damage...?
"...Phase 1 program supports plan to start clinical trials in H2 2022 for NervGen's NVG-291 in spinal cord injury, multiple sclerosis and Alzheimer's disease indications
Screening of healthy volunteers has already started for the trial's multiple ascending dose (MAD) portion
In preclinical studies, NVG-291 has been shown to promote repair of nervous system damage...?
-
- Similar Topics
- Replies
- Views
- Last post
-
- 10 Replies
- 2382 Views
-
Last post by NHE
-
- 0 Replies
- 1118 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1038 Views
-
Last post by frodo
-
- 0 Replies
- 1236 Views
-
Last post by DIM
-
- 0 Replies
- 1256 Views
-
Last post by NHE
-
- 0 Replies
- 1087 Views
-
Last post by frodo
-
- 0 Replies
- 1428 Views
-
Last post by DIM
-
- 0 Replies
- 1766 Views
-
Last post by DIM
-
- 0 Replies
- 1195 Views
-
Last post by frodo